Sung Mo Hur

Samsung Medical Center

Papers

1

Total Citations

114

H-Index

1

About

Dr. Sung Mo Hur is a pioneering thyroid surgeon whose work has fundamentally shaped the debate around minimally invasive approaches to thyroid cancer treatment. His research centers on comparative surgical oncology, specifically evaluating the efficacy and safety of robotic, endoscopic, and open thyroid surgeries. Dr. Hur’s most influential contribution is his landmark 2011 study, “Is Robotic Surgery Superior to Endoscopic and Open Surgeries in Thyroid Cancer?”—a highly cited work (114 citations) that critically assessed the emerging role of robotic techniques against established methods. This paper provided crucial evidence on operative outcomes, complication rates, and cosmetic benefits, helping to define best practices in the field. By systematically comparing these surgical modalities, Dr. Hur has guided surgeons in selecting the optimal approach for patients, balancing oncologic rigor with quality of life. His work remains essential reading for endocrine surgeons and oncologists, reflecting a career dedicated to advancing surgical precision and patient-centered care in thyroid oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
114
Total Citations
114
Avg Citations/Paper
🏆 Most Cited Paper
Is Robotic Surgery Superior to Endoscopic and Open Surgeries in Thyroid Cancer?
114 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Samsung Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago